ADT Biotech was incorporated in 2010 with the vision of improving the standard of diagnostic tests and procedures by bringing advanced technologies, quality brands and innovative products to the healthcare markets in the Asia Pacific region. Our goal is to provide faster and more accurate diagnostic tests and technologies and to increase the quality and content of clinically relevant information to support healthcare practitioners in making faster and better treatment decisions, leading the path to improved patient outcomes.ADT offers an extensive range of fully validated CE IVD certified products for infectious diseases, genetic and oncogenetic markers, syndromic multiplex panels for respiratory and gastrointestinal diseases, meningitis and STD’s, fungal infections, sepsis and antimicrobial resistance markers as well as sample preparation and instrumentation. Beyond our range of IVD products, ADT in partnership with QCMD offers the most comprehensive range of External Quality Assessment (EQA) programs and Proficiency Testing (PT) materials, molecular controls and evaluation panels to help monitor and improve quality in the clinical laboratory.